Search - tctmd.com

Displaying 421 - 440 of 1554

Sort: Relevancy | Date

Presentation TCT 2023

TWIST TMVR technology overview

Presenter: Ehud Raanani

October 25, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

What Will the Next Trial Designs Look Like for Renal Denervation?

Presenter: Eric Secemsky

October 24, 2023

Presentation TCT 2023

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials

Presenter: Jayakumar Sreenivasan

October 24, 2023

Presentation TCT 2023

TCT 598: Hemodynamic Assessment of Suboptimal Percutaneous Coronary Intervention outcomes using coronary intravascular imaging based ultrasonic flow ratio and optical flow ratio: Insights from ASET JAPAN Trial

Presenter: Pruthvi Chenniganahosahalli Revaiah

October 24, 2023

Presentation TCT 2023

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

Presenter: Omar Khalique

October 24, 2023

Presentation TCT 2023

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Presenter: Nadira Hamid

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

Presenter: Harigopal Sandhyavenu

October 24, 2023

Presentation TCT 2023

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

Presenter: Tony Das

October 24, 2023

Presentation TCT 2023

TCT 321: FFR-guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 3-Year Results From the FFR REACT Trial

Presenter: Joost Daemen

October 24, 2023

Presentation TCT 2023

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

Presenter: Daniel Snyder

October 24, 2023

Presentation TCT 2023

TCT 142: Impact of Chronic Total Occlusions on Outcomes in The FAME 3 Trial

Presenter: Hisao Otsuki

October 24, 2023

Presentation TCT 2023

Importance of Patient Reported Outcomes

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

TCT 190: The Impact of Age on Fractional Flow Reserve versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention: A FLAVOUR (Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in…

Presenter: Bong-Ki Lee

October 24, 2023

Presentation TCT 2023

An Echo Deep Dive of the PARTNER 5-Year Study

Presenter: Philippe Pibarot

October 24, 2023

Presentation TCT 2023

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

TCT 253: Medication Adjustments Associated With Implantation of a Cardiac Alerting Device: The ALERTS Trial

Presenter: Andrew Kaplan

October 24, 2023

Advertisement

TWIST TMVR technology overview

Are Outcome Trials Necessary for Renal Denervation Therapies?

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

What Will the Next Trial Designs Look Like for Renal Denervation?

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials

TCT 598: Hemodynamic Assessment of Suboptimal Percutaneous Coronary Intervention outcomes using coronary intravascular imaging based ultrasonic flow ratio and optical flow ratio: Insights from ASET JAPAN Trial

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Trialist Perspectives

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

TCT 321: FFR-guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 3-Year Results From the FFR REACT Trial

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

TCT 142: Impact of Chronic Total Occlusions on Outcomes in The FAME 3 Trial

Importance of Patient Reported Outcomes

TCT 190: The Impact of Age on Fractional Flow Reserve versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention: A FLAVOUR (Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in…

An Echo Deep Dive of the PARTNER 5-Year Study

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

TCT 253: Medication Adjustments Associated With Implantation of a Cardiac Alerting Device: The ALERTS Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content